James L. Sublett

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Environmental assessment and exposure control of dust mites: a practice parameter

Jay M. Portnoy, Jeffrey D. Miller, P. Brock Williams et al. · Annals of Allergy Asthma & Immunology · 2013 · 158 citations · Full text

Pharmacy, Environmental Sciences, Toxicology +15

Environmental assessment and exposure control: a practice parameter—furry animals

Jay M. Portnoy, Kevin Kennedy, James L. Sublett et al. · Annals of Allergy Asthma & Immunology · 2012 · 121 citations · Full text

Pharmacy, Environmental Sciences, Toxicology +11

The importance of allergic disease in public health: an iCAALL statement

Mario Sánchez‐Borges, Bryan Martin, Antonella Muraro et al. · World Allergy Organization Journal · 2018 · 101 citations · Full text

Life Sciences, Health Sciences, Immunology +13

Non-compliance in asthmatic children: a study of theophylline levels in a pediatric emergency room population.

James L. Sublett, Pollard Sj, Kadlec Gj et al. · PubMed · 1979 · 79 citations

Pharmacy, Pediatrics, Pharmacotherapy +14